Richard is responsible for the design and delivery of all clinical research across the Health & Wellness business, with a particular focus on microbiome solutions. Research currently spans human, pet and vet programmes. He and his team work in collaboration with many of the world’s leading universities and research institutions, forming partnerships to deliver innovative clinical research. Richard is also ADM’s representative on multiple international scientific bodies, including the International Probiotics Association and the Pharmabiotic Research Institute.